SGMT·786700104·US·equity·Healthcare - Biotechnology-13D/G
SGMT (SAGIMET BIOSCIENCES INC) is held by 54 institutional investors as of Q1 2026. Largest holders: Woodline Partners LP ($5.2M), MARSHALL WACE, LLP ($5M), BAKER BROS. ADVISORS LP ($5M). Net institutional sentiment: Mixed.
See how SGMT's score breaks down across 4 SEC sources
Showing 1-20 of 58
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer